A new clinic-ready web-based risk prediction tool called PsyMetRiC is now available to forecast the risk of young people with psychosis developing cardiometabolic disorders such as obesity, metabolic syndrome and diabetes. The algorithms behind PsyMetRiC have been specifically tailored for young people with psychosis, and predict clinically significant weight gain within one year, metabolic syndrome … Read more
Published in The Lancet Neurology, a new review from the University of Colorado Anschutz in collaboration with UT Southwestern Medical Center, offers the latest scientific explanations for why ketogenic diets reduce seizures in people with epilepsy. The paper brings together insights from both laboratory discoveries and real‑world patient outcomes, showing that ketogenic diets do far more … Read more
Nearly 300 abstracts on prostate cancer research from around the world will be presented at the European Association of Urology Congress (EAU26), taking place in London from 13–16 March 2026. Highlights of some of the key advances in the prostate cancer screening field are detailed below. Tobias Nordström is a clinical urologist and Associate Professor … Read more
Starting the day’s first meal earlier may shift the body’s daily glucose rhythm and reduce overnight glucose levels in gestational diabetes, highlighting meal timing as a potential lifestyle factor worth exploring in pregnancy care. Study: Early meal timing improves nocturnal glucose in pregnancies complicated by gestational diabetes. Image Credit: Natalia Deriabina / Shutterstock In a … Read more
Food allergies are serious and, for some, potentially deadly. And yet, despite decades of research into allergies and what causes them, very little is known about why the vast majority of people are able to tolerate foods that can sicken or even kill others. “We know a lot about what the immune system sees and does if … Read more
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban is safer than rivaroxaban, with fewer bleeding complications. Venous thrombosis occurs when a blood clot lodges in the veins of the legs or lungs. … Read more
The rise in invasive cosmetic procedures demands tighter regulation, better consumer protection, and greater awareness to protect patient safety and reduce cosmetic tourism, argue experts in The BMJ today. The global market for cosmetic procedures is growing rapidly and is projected to exceed $180bn by 2033, note Danielle Griffiths at the University of Liverpool and colleagues. Invasive … Read more
Want to stay on top of the science and politics driving biotech today? Sign up to… The post Leucovorin, Epstein & FDA: Novo Health Readout appeared first on Archynetys. Source link
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The findings highlight the potential importance of these under-studied cells in breast cancer progression. Circulating tumors cells are … Read more
A multi-center study led by researchers at Cincinnati Children’s sheds surprising new light on why some newborns become severely ill from Escherichia coli infection, but others do not. Turns out that most babies are immune because of germ-fighting antibodies they receive from their moms. The study, published March 11, 2026, in the prestigious journal Nature, … Read more